Andrew D. Hershey
Has grant
Research Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
Recent Grants
Grant: Close
Amitriptyline and Topiramate in the Prevention of Childhood Migraine
Open Date: 2011-09-30
Close Date: 2016-08-31
Grant: Close
Amitriptyline and Topiramate in the Prevention of Childhood Migraine
Open Date: 2011-09-30
Close Date: 2016-08-31
Grant: Close
Genomics of Pediatric Headache Disorders
Open Date: 2003-07-15
Close Date: 2007-06-30
Grant: Close
Genomics of Pediatric Headache Disorders
Open Date: 2003-07-15
Close Date: 2007-06-30
Articles (11)
Objective To examine trends in diagnosis of headache and migraine in a large pediatric neurology cohort, and test whether an electronic health record (EHR)‐integrated headache questionnaire can increase specificity of diagnosis and likelihood of prescribing migraine treatment. Background Under‐diagnosis of migraine contributes to the burden of disease. As we founded our Pediatric Headache Program in 2013, we recognized that the proportion of patients with headache who were given a diagnosis of migraine was much lower than expected. Methods We developed a patient headache questionnaire, initially on paper (2013–2014), then in an electronic database (2014–2016), and finally integrated into our electronic health record (pilot: 2016, full: May 2017). We compared diagnoses and prescribed treatments for new patients who were given a headache diagnosis, looking at trends in the proportion of patients given specific diagnoses (migraine, etc.) versus the non‐specific diagnosis, “headache.” Next, we conducted a prospective cohort study to test for association between provider use of the form and the presence of a specific diagnosis, then for an association between specific diagnosis and prescription of migraine treatment. Results Between July 2011 and December 2022 the proportion of new headache patients who were given a diagnosis of migraine increased 9.7% and non‐specific headache diagnoses decreased 21.0%. In the EHR cohort (June 2017–December 2022, n = 15,122), use of the provider form increased the rate of specific diagnosis to 87.2% (1839/2109) compared to 75.5% (5708/7560) without a patient questionnaire, nearly doubling the odds of making a specific diagnosis (odds ratio [OR] 1.90, 95% confidence interval [CI]: 1.65–2.19). Compared to those given only a non‐specific headache diagnosis who were prescribed a migraine therapy 53.7% (1766/3286) of the time, 75.3% (8914/11836) of those given a specific diagnosis received a migraine therapy, more than doubling the odds of prescription (OR 2.39, 95% CI: 2.20–2.60). Conclusions Interventions to improve specificity of diagnosis were effective and led to increased rates of prescription of migraine treatments. These results have been sustained over several years. This headache questionnaire was adapted into the Foundation system of EpicCare, so it is broadly available as a clinical and research tool for institutions that use this EHR software.
Year:
2023
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Year:
2021
Collaborators (7)
Christopher King
University of Cincinnati College of Medicine
Serena Orr
Assistant Professor
University of Calgary
Samantha Irwin
Associate Professor
University of Texas at Austin
Marina Vives-Mestres
Teaching
Universitat de Girona
Carlyn Patterson Gentile
Assistant Professor
University of Pennsylvania Perelman School of Medicine
Hadas Nahman-Averbuch
Assistant Professor
Washington University in Saint Louis School of Medicine
Daniel Lax
Director, Pediatric Headache
Montefiore Medical Center
Make your next move.
Prepare your application
Review drafts before you send them.